File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids

TitleA Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids
Authors
KeywordsGanoderma lucidum
lucidenic acids
pharmacological effects
Issue Date12-Feb-2023
PublisherMDPI
Citation
Molecules, 2023, v. 28, n. 4 How to Cite?
Abstract

Ganoderma lucidum has long been used as a multi-purpose plant and functional food. The pharmacological properties of G. lucidum are primarily attributed to its polysaccharides and triterpenoids. Ganoderic and lucidenic acids are the two major triterpenoids groups in G. lucidum. Despite the discovery of 22 types of lucidenic acids, research on lucidenic acids is significantly less extensive compared to that on ganoderic acid. To the best of our knowledge, for the first time, in this review, we aimed to summarize the sources, contents, chemical structures, and pharmacological effects, including anti-cancer, anti-inflammatory, antioxidant, anti-viral, neuroprotective, anti-hyperlipidemic, anti-hypercholesterolemic, and anti-diabetic properties, of lucidenic acids. Studies on lucidenic acids are still preliminary and have several limitations. Therefore, more in-depth studies with optimal designs are essential for the development of lucidenic acids as medicines, functional foods, and nutraceuticals.


Persistent Identifierhttp://hdl.handle.net/10722/328999
ISSN
2023 Impact Factor: 4.2
2023 SCImago Journal Rankings: 0.744
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorZheng, Chengwen-
dc.contributor.authorRangsinth, Panthakarn-
dc.contributor.authorShiu, Ho Ting-
dc.contributor.authorWang, Wen-
dc.contributor.authorLi, Renkai-
dc.contributor.authorLi, Jingjing-
dc.contributor.authorKwan, Yiu Wa-
dc.contributor.authorLeung, George Pak Heng-
dc.date.accessioned2023-08-05T07:54:31Z-
dc.date.available2023-08-05T07:54:31Z-
dc.date.issued2023-02-12-
dc.identifier.citationMolecules, 2023, v. 28, n. 4-
dc.identifier.issn1420-3049-
dc.identifier.urihttp://hdl.handle.net/10722/328999-
dc.description.abstract<p>Ganoderma lucidum has long been used as a multi-purpose plant and functional food. The pharmacological properties of G. lucidum are primarily attributed to its polysaccharides and triterpenoids. Ganoderic and lucidenic acids are the two major triterpenoids groups in G. lucidum. Despite the discovery of 22 types of lucidenic acids, research on lucidenic acids is significantly less extensive compared to that on ganoderic acid. To the best of our knowledge, for the first time, in this review, we aimed to summarize the sources, contents, chemical structures, and pharmacological effects, including anti-cancer, anti-inflammatory, antioxidant, anti-viral, neuroprotective, anti-hyperlipidemic, anti-hypercholesterolemic, and anti-diabetic properties, of lucidenic acids. Studies on lucidenic acids are still preliminary and have several limitations. Therefore, more in-depth studies with optimal designs are essential for the development of lucidenic acids as medicines, functional foods, and nutraceuticals.</p>-
dc.languageeng-
dc.publisherMDPI-
dc.relation.ispartofMolecules-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectGanoderma lucidum-
dc.subjectlucidenic acids-
dc.subjectpharmacological effects-
dc.titleA Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids-
dc.typeArticle-
dc.identifier.doi10.3390/molecules28041756-
dc.identifier.scopuseid_2-s2.0-85149053659-
dc.identifier.volume28-
dc.identifier.issue4-
dc.identifier.eissn1420-3049-
dc.identifier.isiWOS:000940970300001-
dc.identifier.issnl1420-3049-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats